资产负债表（Marinus Pharmaceuticals Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | ||||||||
| 现金及现金等价物(元) | 120,572,000.00 | 140,437,000.00 | 127,787,000.00 | 146,904,000.00 | 240,551,000.00 | 168,249,000.00 | 92,326,000.00 | 126,319,000.00 |
| 应收账款及票据(元) | 3,799,000.00 | 4,281,000.00 | 5,234,000.00 | 11,693,000.00 | 6,348,000.00 | 3,398,000.00 | 3,000,000.00 | 2,489,000.00 |
| 预付款项及其他应收款流动(元) | 8,746,000.00 | 11,667,000.00 | 11,365,000.00 | 9,064,000.00 | 5,402,000.00 | 5,255,000.00 | 5,765,000.00 | 6,263,000.00 |
| 存货(元) | 2,413,000.00 | 2,736,000.00 | 2,674,000.00 | 37,000.00 | 77,000.00 | 104,000.00 | - | - |
| 短期投资(元) | 29,716,000.00 | 35,919,000.00 | 47,549,000.00 | 52,297,000.00 | - | - | - | - |
| 流动资产合计(元) | 165,246,000.00 | 195,040,000.00 | 194,609,000.00 | 219,995,000.00 | 252,378,000.00 | 177,006,000.00 | 101,091,000.00 | 135,071,000.00 |
| 非流动资产： | ||||||||
| 物业、厂房及设备(元) | 3,843,000.00 | 3,909,000.00 | 3,938,000.00 | 4,037,000.00 | 4,236,000.00 | 5,520,000.00 | 5,561,000.00 | 2,989,000.00 |
| 非流动资产其他项目(元) | 1,819,000.00 | 1,857,000.00 | 2,653,000.00 | 2,785,000.00 | 2,904,000.00 | 2,315,000.00 | 2,725,000.00 | 2,750,000.00 |
| 非流动资产合计(元) | 5,662,000.00 | 5,766,000.00 | 6,591,000.00 | 6,822,000.00 | 7,140,000.00 | 7,835,000.00 | 8,286,000.00 | 5,739,000.00 |
| 总资产(元) | 170,908,000.00 | 200,806,000.00 | 201,200,000.00 | 226,817,000.00 | 259,518,000.00 | 184,841,000.00 | 109,377,000.00 | 140,810,000.00 |
| 流动负债： | ||||||||
| 应付账款及票据(元) | 15,554,000.00 | 10,326,000.00 | 6,152,000.00 | 4,466,000.00 | 4,461,000.00 | 1,622,000.00 | 3,299,000.00 | 4,671,000.00 |
| 其他应付款及应计费用(元) | 25,070,000.00 | 20,229,000.00 | 19,451,000.00 | 17,048,000.00 | 20,556,000.00 | 19,428,000.00 | 19,811,000.00 | 14,865,000.00 |
| 流动负债合计(元) | 40,624,000.00 | 30,555,000.00 | 25,603,000.00 | 21,514,000.00 | 25,017,000.00 | 21,050,000.00 | 23,110,000.00 | 19,536,000.00 |
| 非流动负债： | ||||||||
| 应付账款及票据非流动(元) | 61,423,000.00 | 64,783,000.00 | 68,136,000.00 | 71,498,000.00 | 71,018,000.00 | 70,780,000.00 | 70,350,000.00 | 69,927,000.00 |
| 其他长期应付款(元) | 33,766,000.00 | 32,855,000.00 | 31,950,000.00 | 30,893,000.00 | 29,857,000.00 | - | - | - |
| 非流动负债其他项目(元) | 18,330,000.00 | 18,076,000.00 | 18,172,000.00 | 17,827,000.00 | 17,626,000.00 | 11,007,000.00 | 11,114,000.00 | 10,942,000.00 |
| 非流动负债合计(元) | 113,519,000.00 | 115,714,000.00 | 118,258,000.00 | 120,218,000.00 | 118,501,000.00 | 81,787,000.00 | 81,464,000.00 | 80,869,000.00 |
| 总负债(元) | 154,143,000.00 | 146,269,000.00 | 143,861,000.00 | 141,732,000.00 | 143,518,000.00 | 102,837,000.00 | 104,574,000.00 | 100,405,000.00 |
| 股东权益： | ||||||||
| 普通股(元) | 55,000.00 | 55,000.00 | 51,000.00 | 50,000.00 | 50,000.00 | 37,000.00 | 37,000.00 | 37,000.00 |
| 优先股(元) | - | - | - | 4,043,000.00 | 4,043,000.00 | 4,043,000.00 | 4,043,000.00 | 4,302,000.00 |
| 股本溢价(元) | 588,656,000.00 | 584,710,000.00 | 554,587,000.00 | 546,169,000.00 | 542,428,000.00 | 474,133,000.00 | 470,222,000.00 | 466,132,000.00 |
| 留存收益(元) | -571,926,000.00 | -530,157,000.00 | -497,185,000.00 | -465,251,000.00 | -430,521,000.00 | -396,209,000.00 | -469,499,000.00 | -430,066,000.00 |
| 累计其他全面收益(元) | -20,000.00 | -71,000.00 | -114,000.00 | 74,000.00 | - | - | - | - |
| 归属于母公司股东权益(元) | 16,765,000.00 | 54,537,000.00 | 57,339,000.00 | 85,085,000.00 | 116,000,000.00 | 82,004,000.00 | 4,803,000.00 | 40,405,000.00 |
| 股东权益合计(元) | 16,765,000.00 | 54,537,000.00 | 57,339,000.00 | 85,085,000.00 | 116,000,000.00 | 82,004,000.00 | 4,803,000.00 | 40,405,000.00 |
| 负债及股东权益合计(元) | 170,908,000.00 | 200,806,000.00 | 201,200,000.00 | 226,817,000.00 | 259,518,000.00 | 184,841,000.00 | 109,377,000.00 | 140,810,000.00 |
| 公告日期 | 2024-03-05 | 2023-11-07 | 2023-08-10 | 2023-05-11 | 2023-03-09 | 2022-11-07 | 2022-08-11 | 2022-05-12 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |